INSM - Insmed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INSM is currently covered by 17 analysts with an average price target of $113.73. This is a potential upside of $15.49 (15.77%) from yesterday's end of day stock price of $98.24.

Insmed's activity chart (see below) currently has 93 price targets and 153 ratings on display. The stock rating distribution of INSM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 94.11% with an average time for these price targets to be met of 418.65 days.

Highest price target for INSM is $120, Lowest price target is $83, average price target is $94.31.

Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 11-Jun-2025. First documented stock forecast 05-Sep-2014.

Currently out of the existing stock ratings of INSM, 83 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$102

$2.51 (2.52%)

$90

21 days ago
(11-Jun-2025)

13/13 (100%)

$4.02 (4.10%)

489

Buy

$120

$20.51 (20.62%)

$90

21 days ago
(11-Jun-2025)

17/18 (94.44%)

$22.02 (22.47%)

329

Buy

$109

$9.51 (9.56%)

$96

21 days ago
(11-Jun-2025)

9/10 (90%)

$11.02 (11.25%)

237

Buy

$112

$12.51 (12.57%)

$102

21 days ago
(11-Jun-2025)

5/6 (83.33%)

$14.02 (14.31%)

335

Buy

$119

$19.51 (19.61%)

$107

21 days ago
(11-Jun-2025)

3/5 (60%)

$21.02 (21.45%)

136

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INSM (Insmed) average time for price targets to be met?

On average it took 418.65 days on average for the stock forecasts to be realized with a an average price target met ratio 94.11

Which analyst has the current highest performing score on INSM (Insmed) with a proven track record?

JENNIFER KIM

Which analyst has the most public recommendations on INSM (Insmed)?

Jennifer Kim works at CANTOR FITZGERALD and has 2 price targets and 3 ratings on INSM

Which analyst is the currently most bullish on INSM (Insmed)?

Dana Flanders with highest potential upside - $24.75

Which analyst is the currently most reserved on INSM (Insmed)?

Liisa Bayko with lowest potential downside - -$57.49

Insmed in the News

Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates

Insmed INSM reported a first-quarter 2025 loss of $1.42 per share, which was wider than the Zacks Consensus Estimate of a loss of $1.36. In the year-ago quarter, the company posted a loss of $1.06 per share. The company generated total quarterly revenues of $92.8 million, which rose 23% year over year. Quarterly sales were...

Is Insmed Incorporated (INSM) One of the Best Cancer Stocks to Invest in for Long-Term Gain?

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against other best cancer stocks to invest in for long-term gain. Surging Cancer Cases and Costs Drive Growth in the Global Oncology Market...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?